In another work by Lang et al., about 57 patients with NAFLD were genotyped for the PNLPLA3 mutation and their daily food intake was self-reported for 14 days; after this period, stool samples were sequenced, showing a reduction in two bacterial species, i.e., Faecalumbacterium and Prevotella, and an increased presence of Gemmiger Gram-negative bacteria in PNPLA3 carriers [98]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.